Powered by: Motilal Oswal
2025-04-08 12:18:54 pm | Source: Accord Fintech
Bajaj Healthcare rises on acquiring Genrx Pharmaceuticals
Bajaj Healthcare rises on acquiring Genrx Pharmaceuticals

Bajaj Healthcare is currently trading at Rs. 575.00, up by 5.05 points or 0.89% from its previous closing of Rs. 569.95 on the BSE.

The scrip opened at Rs. 589.10 and has touched a high and low of Rs. 598.55 and Rs. 571.00 respectively. So far 18589 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 744.90 on 19-Mar-2025 and a 52 week low of Rs. 265.00 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 701.00 and Rs. 507.65 respectively. The current market cap of the company is Rs. 1819.20 crore.

The promoters holding in the company stood at 59.19%, while Institutions and Non-Institutions held 3.37% and 37.45% respectively.

Bajaj Healthcare has successfully acquired Genrx Pharmaceuticals (in Liquidation) as a going concern, as per the Sale Certificate dated April 4, 2025, issued by the Official Liquidator. The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% control of the target entity.

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here